1. Search Result
Search Result
Results for "

Cxcl9

" in MedChemExpress (MCE) Product Catalog:

7

Inhibitors & Agonists

1

Peptides

2

Inhibitory Antibodies

2

Natural
Products

7

Recombinant Proteins

1

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-P990255

    CXCR Others
    Anti-Mouse CXCL9/MIG Antibody (MIG-2F5.5) is a Armenian hamster-derived IgG, κ type antibody inhibitor, targeting to mouse CXCL9/MIG.
    Anti-Mouse CXCL9/MIG Antibody (MIG-2F5.5)
  • HY-W505771

    Fungal Infection Inflammation/Immunology Cancer
    Seselin is an anticancer, antinociceptive, anti-inflammatory and antifungal agent. Seselin is orally active .
    Seselin
  • HY-RS03396

    Small Interfering RNA (siRNA) Others

    CXCL9 Human Pre-designed siRNA Set A contains three designed siRNAs for CXCL9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    CXCL9 Human Pre-designed siRNA Set A
    CXCL9 Human Pre-designed siRNA Set A
  • HY-P10301

    CXCR Cancer
    CXCL9(74-103) is a derivative peptide of CXCL9 that has a high affinity for glycosaminoglycans (GAGs) and can bind to GAGs. CXCL9(74-103) possesses anti-angiogenic properties, capable of reducing EGF, VEGF165, and FGF-2-mediated angiogenesis processes in vitro, without exhibiting cytotoxicity .
    CXCL9(74-103)
  • HY-P990393

    CXCR Inflammation/Immunology
    Anti-CXCL9 Antibody is a humanized antibody expressed in CHO cells, targeting CXCL9. The Anti-CXCL9 Antibody contains huIgG1 heavy chain and huκ light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for Anti-CXCL9 Antibody can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).
    Anti-CXCL9 Antibody
  • HY-167884

    JAK Inflammation/Immunology
    PF-1367550 is a pan-JAK inhibitor. PF-1367550 can decrease the levels of release of CXCL9, CXCL10 and CXCL11 from primary airway epithelial cells .
    PF-1367550
  • HY-162415

    c-Fms Apoptosis Cancer
    CSF1R-IN-22 (Compound C19) is an orally effective CSF-1R selective inhibitor (IC50<6 nM). CSF1R-IN-22 enhances the secretion of CXCL9 from M2 macrophages, increases CD8 + T cell infiltration. CSF1R-IN-22 boosts anti-tumor immune responses of anti-PD-1, and induces apoptosis in tumor cells. CSF1R-IN-22 can effectively reprogram M2-like TAMs (tumor-associated macrophages) to the M1 phenotype and reshape the TME by inducing the recruitment of CD8 + T cells into tumors and reducing the infiltration of immunosuppressive Tregs and MDSCs .
    CSF1R-IN-22

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: